Effectiveness of PEA Compared to Placebo on Acute Menstrual Pain
Status:
Not yet recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed
Palmitoylethanolamide (PEA) compared to placebo on menstrual pain in otherwise healthy
participants 18 years and over.